Notice Information
Notice Title
Brain Health Community Assessment for Trials Service
Notice Description
Health Data Research UK (HDR UK) and UK Dementia Research Institute (UK DRI) are working in partnership to deliver the Dementia Trials Accelerator (DTA). The DTA, supporting the Government's Dame Barbara Windsor Dementia Goals programme and funded by the Medical Research Council (MRC), aims to rapidly identify a large group of people who are at risk of, or diagnosed with, early-stage dementia. This will boost opportunities for these people to participate in clinical trials, improve research inclusion and reduce the high screening failure rates currently observed in dementia trials.
Lot Information
Lot 1
Programme Vision: The DTA vision is for the UK to become the destination of choice for late-phase clinical trials in dementia and neurodegenerative diseases. The aims of the DTA are to: 1. Increase trial recruitment by identifying potential participants in trials by creating a "biomarker toolbox". This toolbox will incorporate one or more of: genetic or clinical risk scores, blood-based biomarkers and clinical measurements of subjects living with or at risk of dementia and related neurodegenerative disorders 2. Work with existing UK patient or population cohorts to approach people for clinical trials to identify potential participants 3. Accelerate low-cost delivery identification of potential participants in dementia and neurodegenerative trials with community-based, digitally enabled, trial pre-screening 4. Accelerate collaborative neurodegenerative research through assembly of a secure UK wide AI-enabled data platform that makes multi-dimensional FAIR (findable, accessible, interoperable, reusable) through trustworthy and secure data environment(s) 5. Prioritise the needs of industry innovators, patients and the public with an iterative engagement with stakeholders Service Required: Brain Health Community Assessment for Trials Service is central to this vision. It will provide pre-screening for a range of dementia and neurodegenerative clinical trials close to where people live as recommended by the O'Shaughnessy Review. The appointed provider will deliver comprehensive services, including: 1. Appointment booking system that enables participants to book appointments directly through a portal; 2. Booking system able to receive information from and interface via secure integration with data partners; 3. Telephone and email support with appointment booking if needed by participants; 4. Identity check and verifying or obtaining informed consent; 5. Complete 10,000 appointments - one appointment per participant to deliver; * community phlebotomy service; * digital cognitive and 'day-to-day function' assessment performed using electronic device in a quiet location; * physical measurements: height, weight, blood pressure; 6. Blood sample processing; 7. Sample storage, tracking and shipment to a chosen UK location(s); 8. Data collection, storage and sharing. The service required will be a pilot with appointments across England, with plans to expand to underserved areas. The aim is to identify up to 10,000 potential trial participants over one year. Providers must ensure accessibility and provide flexible service times which accommodates those who have daytime commitments. They must also comply with regulatory standards for sample handling, participant confidentiality, and data security. This procurement marks the first phase of a broader initiative, future phases of which will include coverage of the four nations of the UK, subject to a separate procurement process.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-04c2ea
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/040181-2025
- Current Stage
- Award
- All Stages
- Planning, Tender, Award
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
73 - Research and development services and related consultancy services
75 - Administration, defence and social security services
85 - Health and social work services
-
- CPV Codes
73110000 - Research services
73210000 - Research consultancy services
75122000 - Administrative healthcare services
85323000 - Community health services
Notice Value(s)
- Tender Value
- £2,000,000 £1M-£10M
- Lots Value
- £2,000,000 £1M-£10M
- Awards Value
- Not specified
- Contracts Value
- £1,946,628 £1M-£10M
Notice Dates
- Publication Date
- 15 Jul 20257 months ago
- Submission Deadline
- 14 Apr 2025Expired
- Future Notice Date
- 24 Jan 2025Expired
- Award Date
- 10 Jul 20257 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- HEALTH DATA RESEARCH UK
- Additional Buyers
- Contact Name
- Not specified
- Contact Email
- dtaprocurement@hdruk.ac.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- NW1 2BE
- Post Town
- North West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI36 Camden
- Delivery Location
- Not specified
-
- Local Authority
- Camden
- Electoral Ward
- Regent's Park
- Westminster Constituency
- Holborn and St Pancras
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-04c2ea-2025-07-15T17:04:18+01:00",
"date": "2025-07-15T17:04:18+01:00",
"ocid": "ocds-h6vhtk-04c2ea",
"description": "HDR UK and UK DRI invite interested parties to express their interest and engage with this market engagement process. This notice serves as an opportunity for providers to refine service specifications collaboratively before the formal procurement process begins. To respond to this invitation and participate in market engagement, please email procurement@hdr.ac.uk referencing Dementia Trials Accelerator.",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-04c2ea",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Brain Health Community Assessment for Trials Service",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "85323000",
"description": "Community health services"
},
"mainProcurementCategory": "services",
"description": "Health Data Research UK (HDR UK) and UK Dementia Research Institute (UK DRI) are working in partnership to deliver the Dementia Trials Accelerator (DTA). The DTA, supporting the Government's Dame Barbara Windsor Dementia Goals programme and funded by the Medical Research Council (MRC), aims to rapidly identify a large group of people who are at risk of, or diagnosed with, early-stage dementia. This will boost opportunities for these people to participate in clinical trials, improve research inclusion and reduce the high screening failure rates currently observed in dementia trials.",
"lots": [
{
"id": "1",
"description": "Programme Vision: The DTA vision is for the UK to become the destination of choice for late-phase clinical trials in dementia and neurodegenerative diseases. The aims of the DTA are to: 1. Increase trial recruitment by identifying potential participants in trials by creating a \"biomarker toolbox\". This toolbox will incorporate one or more of: genetic or clinical risk scores, blood-based biomarkers and clinical measurements of subjects living with or at risk of dementia and related neurodegenerative disorders 2. Work with existing UK patient or population cohorts to approach people for clinical trials to identify potential participants 3. Accelerate low-cost delivery identification of potential participants in dementia and neurodegenerative trials with community-based, digitally enabled, trial pre-screening 4. Accelerate collaborative neurodegenerative research through assembly of a secure UK wide AI-enabled data platform that makes multi-dimensional FAIR (findable, accessible, interoperable, reusable) through trustworthy and secure data environment(s) 5. Prioritise the needs of industry innovators, patients and the public with an iterative engagement with stakeholders Service Required: Brain Health Community Assessment for Trials Service is central to this vision. It will provide pre-screening for a range of dementia and neurodegenerative clinical trials close to where people live as recommended by the O'Shaughnessy Review. The appointed provider will deliver comprehensive services, including: 1. Appointment booking system that enables participants to book appointments directly through a portal; 2. Booking system able to receive information from and interface via secure integration with data partners; 3. Telephone and email support with appointment booking if needed by participants; 4. Identity check and verifying or obtaining informed consent; 5. Complete 10,000 appointments - one appointment per participant to deliver; * community phlebotomy service; * digital cognitive and 'day-to-day function' assessment performed using electronic device in a quiet location; * physical measurements: height, weight, blood pressure; 6. Blood sample processing; 7. Sample storage, tracking and shipment to a chosen UK location(s); 8. Data collection, storage and sharing. The service required will be a pilot with appointments across England, with plans to expand to underserved areas. The aim is to identify up to 10,000 potential trial participants over one year. Providers must ensure accessibility and provide flexible service times which accommodates those who have daytime commitments. They must also comply with regulatory standards for sample handling, participant confidentiality, and data security. This procurement marks the first phase of a broader initiative, future phases of which will include coverage of the four nations of the UK, subject to a separate procurement process.",
"status": "cancelled",
"value": {
"amount": 2000000,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 540
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"awardCriteria": {
"criteria": [
{
"name": "Quality",
"type": "quality",
"description": "70"
},
{
"name": "Cost",
"type": "cost",
"description": "30"
}
]
}
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "73110000",
"description": "Research services"
},
{
"scheme": "CPV",
"id": "73210000",
"description": "Research consultancy services"
},
{
"scheme": "CPV",
"id": "75122000",
"description": "Administrative healthcare services"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
},
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"communication": {
"futureNoticeDate": "2025-01-24T00:00:00Z"
},
"submissionMethod": [
"electronicSubmission"
],
"coveredBy": [
"GPA"
],
"value": {
"amount": 2000000,
"currency": "GBP"
},
"participationFees": [
{
"id": "1",
"type": [
"document"
]
}
],
"submissionMethodDetails": "https://www.hdruk.ac.uk/jobs/brain-health-clinical-trials-data-augmentation-service/",
"documents": [
{
"id": "economic1",
"documentType": "economicSelectionCriteria"
},
{
"id": "technical1",
"documentType": "technicalSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"tenderPeriod": {
"endDate": "2025-04-14T13:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2025-04-14T14:00:00+01:00"
},
"bidOpening": {
"date": "2025-04-14T14:00:00+01:00",
"description": "The Authorities do not have use of a tendering portal for this procurement, or sufficient controls for receipt of physical tenders via post. Tenders are to be submitted via email, contained within a single .zip folder attachment, and password protected (locked). Only locked Tenders received via email will be accepted. Passwords must not be provided to the Authorities prior to the submission deadline. Only locked Tenders received via email by the submission deadline will be accepted. After the deadline, the Authorities will log received locked Tenders and contact Tenderers via email to request passwords. These must be supplied promptly upon request, but not prior to the deadline. This will ensure that the Authorities will not be able to access or open Tenders before the deadline."
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-CHC-1194431",
"name": "HEALTH DATA RESEARCH UK",
"identifier": {
"legalName": "HEALTH DATA RESEARCH UK",
"id": "1194431",
"scheme": "GB-CHC"
},
"address": {
"streetAddress": "215 Euston Road",
"locality": "London",
"region": "UKI31",
"postalCode": "NW12BE",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "dtaprocurement@hdruk.ac.uk",
"url": "https://www.hdruk.ac.uk/jobs/brain-health-clinical-trials-data-augmentation-service/"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.hdruk.ac.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"description": "Charity in receipt of public funding"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-CHC-1179589",
"name": "UK DRI LTD",
"identifier": {
"legalName": "UK DRI LTD",
"id": "1179589",
"scheme": "GB-CHC"
},
"address": {
"streetAddress": "338 Euston Road",
"locality": "London",
"region": "UKI31",
"countryName": "United Kingdom",
"postalCode": "NW13BT"
},
"contactPoint": {
"email": "dtaprocurement@hdruk.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://ukdri.ac.uk/"
}
},
{
"id": "GB-FTS-132182",
"name": "Public Procurement Review Service (Cabinet Office)",
"identifier": {
"legalName": "Public Procurement Review Service (Cabinet Office)"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
},
{
"id": "GB-COH-08811416",
"name": "Inuvi Health Limited",
"identifier": {
"legalName": "Inuvi Health Limited",
"id": "08811416",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Unit 10 Millars Brook Business Park",
"locality": "Wokingham",
"region": "UK",
"postalCode": "RG412AD",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
}
],
"buyer": {
"id": "GB-CHC-1194431",
"name": "HEALTH DATA RESEARCH UK"
},
"language": "en",
"awards": [
{
"id": "040181-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-08811416",
"name": "Inuvi Health Limited"
}
]
}
],
"contracts": [
{
"id": "040181-2025-1",
"awardID": "040181-2025-1",
"status": "active",
"value": {
"amount": 1946628,
"currency": "GBP"
},
"dateSigned": "2025-07-11T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 8
}
]
}
}